目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global premenstrual syndrome market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global premenstrual syndrome market 2018 - 2022 ($ million)
4.2 Drug Class Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Drug Class
6.1 Market segments
Exhibit 30: Chart on Drug Class - Market share 2023-2028 (%)
Exhibit 31: Data Table on Drug Class - Market share 2023-2028 (%)
6.2 Comparison by Drug Class
Exhibit 32: Chart on Comparison by Drug Class
Exhibit 33: Data Table on Comparison by Drug Class
6.3 Analgesics - Market size and forecast 2023-2028
Exhibit 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
6.4 Oral contraceptives and ovarian suppression agents - Market size and forecast 2023-2028
Exhibit 38: Chart on Oral contraceptives and ovarian suppression agents - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Oral contraceptives and ovarian suppression agents - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Oral contraceptives and ovarian suppression agents - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Oral contraceptives and ovarian suppression agents - Year-over-year growth 2023-2028 (%)
6.5 Antidepressants - Market size and forecast 2023-2028
Exhibit 42: Chart on Antidepressants - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Antidepressants - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Antidepressants - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Antidepressants - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Drug Class
Exhibit 50: Market opportunity by Drug Class ($ million)
Exhibit 51: Data Table on Market opportunity by Drug Class ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
7.3 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 60: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 68: Market opportunity by Distribution Channel ($ million)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 119: AbbVie Inc. - Overview
Exhibit 120: AbbVie Inc. - Product / Service
Exhibit 121: AbbVie Inc. - Key news
Exhibit 122: AbbVie Inc. - Key offerings
12.4 Bayer AG
Exhibit 123: Bayer AG - Overview
Exhibit 124: Bayer AG - Business segments
Exhibit 125: Bayer AG - Key news
Exhibit 126: Bayer AG - Key offerings
Exhibit 127: Bayer AG - Segment focus
12.5 Eli Lilly and Co.
Exhibit 128: Eli Lilly and Co. - Overview
Exhibit 129: Eli Lilly and Co. - Product / Service
Exhibit 130: Eli Lilly and Co. - Key news
Exhibit 131: Eli Lilly and Co. - Key offerings
12.6 GlaxoSmithKline Plc
Exhibit 132: GlaxoSmithKline Plc - Overview
Exhibit 133: GlaxoSmithKline Plc - Business segments
Exhibit 134: GlaxoSmithKline Plc - Key news
Exhibit 135: GlaxoSmithKline Plc - Key offerings
Exhibit 136: GlaxoSmithKline Plc - Segment focus
12.7 Herbalife International of America Inc.
Exhibit 137: Herbalife International of America Inc. - Overview
Exhibit 138: Herbalife International of America Inc. - Product / Service
Exhibit 139: Herbalife International of America Inc. - Key offerings
12.8 Johnson and Johnson
Exhibit 140: Johnson and Johnson - Overview
Exhibit 141: Johnson and Johnson - Business segments
Exhibit 142: Johnson and Johnson - Key news
Exhibit 143: Johnson and Johnson - Key offerings
Exhibit 144: Johnson and Johnson - Segment focus
12.9 Lupin Ltd.
Exhibit 145: Lupin Ltd. - Overview
Exhibit 146: Lupin Ltd. - Product / Service
Exhibit 147: Lupin Ltd. - Key news
Exhibit 148: Lupin Ltd. - Key offerings
12.10 Merck KGaA
Exhibit 149: Merck KGaA - Overview
Exhibit 150: Merck KGaA - Business segments
Exhibit 151: Merck KGaA - Key news
Exhibit 152: Merck KGaA - Key offerings
Exhibit 153: Merck KGaA - Segment focus
12.11 Novartis AG
Exhibit 154: Novartis AG - Overview
Exhibit 155: Novartis AG - Business segments
Exhibit 156: Novartis AG - Key offerings
Exhibit 157: Novartis AG - Segment focus
12.12 Octavius Pharma Pvt. Ltd.
Exhibit 158: Octavius Pharma Pvt. Ltd. - Overview
Exhibit 159: Octavius Pharma Pvt. Ltd. - Product / Service
Exhibit 160: Octavius Pharma Pvt. Ltd. - Key offerings
12.13 Pfizer Inc.
Exhibit 161: Pfizer Inc. - Overview
Exhibit 162: Pfizer Inc. - Product / Service
Exhibit 163: Pfizer Inc. - Key news
Exhibit 164: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 165: Sanofi SA - Overview
Exhibit 166: Sanofi SA - Business segments
Exhibit 167: Sanofi SA - Key news
Exhibit 168: Sanofi SA - Key offerings
Exhibit 169: Sanofi SA - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 178: Viatris Inc. - Overview
Exhibit 179: Viatris Inc. - Business segments
Exhibit 180: Viatris Inc. - Key news
Exhibit 181: Viatris Inc. - Key offerings
Exhibit 182: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 183: Inclusions checklist
Exhibit 184: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 185: Currency conversion rates for US$
13.4 Research methodology
Exhibit 186: Research methodology
Exhibit 187: Validation techniques employed for market sizing
Exhibit 188: Information sources
13.5 List of abbreviations
Exhibit 189: List of abbreviations